Key facts
- This page summarizes Gordon Dunn's Form 4 filing for Quoin Pharmaceuticals, Ltd. (QNRX).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 27 Dec 2024, 17:16.
Gordon Dunn - 23 Dec 2024 Form 4 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- QNRX
- Reported as of
- 23 Dec 2024
- Net transaction value
- +$54,999
- SEC form
- 4
- Accepted by SEC
- 27 Dec 2024, 17:16:15 UTC
- Prior SEC filing
- 10 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gordon Dunn
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gordon Dunn filed Form 4 for Quoin Pharmaceuticals, Ltd. (QNRX) on 27 Dec 2024.
Change
- Previous filing in this sequence was filed on 10 Dec 2024.
- Current net transaction value: +$54,999.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QNRX
transaction
Ordinary Shares
Purchase
- Transaction value
- $54,999
- Shares
- +122,221
- Change %
- +424%
- Price
- $0.4500
- Shares after
- 151,077
- Date
- 23 Dec 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QNRX
transaction
Derivative
Series F Warrants (right to buy)
Purchase
- Transaction value
- Shares
- +122,221
- Change %
- Price
- Shares after
- 122,221
- Date
- 23 Dec 2024
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
- 122,221
- Exercise price
- $0.4500
- Footnotes
- F2, F3
QNRX
transaction
Derivative
Series G Warrants (right to buy)
Purchase
- Transaction value
- Shares
- +122,221
- Change %
- Price
- Shares after
- 122,221
- Date
- 23 Dec 2024
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
- 122,221
- Exercise price
- $0.4500
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
Footnote F2
Each ADS purchased together with a Series F Warrant to purchase one ADS and a Series G Warrant to purchase one ADS in the Issuer's public offering which closed on December 23, 2024, at a combined public offering price of $0.45. The Series F Warrants and the Series G Warrants are collectively referred to as the "Warrants."
Footnote F3
The Warrants were exercisable immediately, subject to a beneficial ownership cap.